{"id":18268,"date":"2014-07-21T02:30:00","date_gmt":"2014-07-21T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/tumori-gli-oncologi-a-lorenzin-inaccettabili-le-disparita-di-accesso-ai-farmaci-innovativi\/"},"modified":"2014-07-21T02:30:00","modified_gmt":"2014-07-21T00:30:00","slug":"tumori-gli-oncologi-a-lorenzin-inaccettabili-le-disparita-di-accesso-ai-farmaci-innovativi","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/tumori-gli-oncologi-a-lorenzin-inaccettabili-le-disparita-di-accesso-ai-farmaci-innovativi\/","title":{"rendered":"Tumors. Oncologists to Lorenzin: &quot;The disparities in access to innovative drugs are unacceptable&quot;"},"content":{"rendered":"<p>&nbsp;<b><i><span style=\"font-size: 12pt; font-family: Georgia, serif;\">For experts, this violates the right to health of patients. Thus in an open letter addressed to the Minister of Health, Aiom and Cipomo denounce the situation by threatening an appeal to the Consulta. &quot;The times set for making these therapies available are not respected. Serious discrimination for the sick&quot;.<\/span><\/i><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom:6.0pt\"><span style=\"font-size: large;\"><span class=\"testorossodata\"><b><span style=\"font-family: Georgia, serif; color: rgb(193, 12, 5); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\">21 JULY<\/span><\/b><\/span><span class=\"apple-converted-space\"><span style=\"font-family: Arial, sans-serif; color: rgb(51, 51, 51); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\">&nbsp;<\/span><\/span><span style=\"font-family: Arial, sans-serif; color: rgb(51, 51, 51); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\">\u2013 Italian oncologists ask, in one <\/span><\/span><span style=\"font-family: Arial, sans-serif; color: rgb(51, 51, 51); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><b><a href=\"http:\/\/www.aiom.it\/C_Common\/Download.asp?file=\/$Site$\/20140711_Lettera_AIOM-CIPOMO_farmaci_oncologici_classe_Cnn.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: large;\">letter<\/span><\/a><\/b><\/span><span style=\"font-size: large;\"><span style=\"font-family: Arial, sans-serif; color: rgb(51, 51, 51); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"> (<em>download<\/em>&nbsp;<i>pdf<\/i>) addressed to the Minister of Health<span class=\"apple-converted-space\">&nbsp;<\/span><strong>Beatrice Lorenzin<\/strong>, to take urgent action to address the problems associated with unacceptable inequalities in access to innovative anti-cancer medicines. Otherwise, faced with a situation that is creating serious ethical and health problems, Aiom (Italian Association of Medical Oncology) and Cipomo (Italian College of Primary Medical Hospital Oncologists) will appeal to the Constitutional Court.<\/span><span style=\"font-family: Arial, sans-serif; color: rgb(51, 51, 51);\"><br \/> <span style=\"background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\">&nbsp;&quot;Law n.189 of 8 November 2012 (ex &#039;Balduzzi decree&#039;) - reads the letter co-signed by the president Aiom,<span class=\"apple-converted-space\">&nbsp;<\/span><strong>Stefano Cascinu<\/strong>, and by the president Cipomo,<span class=\"apple-converted-space\">&nbsp;<\/span><strong>Gianpiero Fasola<\/strong><span class=\"apple-converted-space\">&nbsp;<\/span>\u2013 pending the negotiation of reimbursement and the price, provides for the automatic inclusion of innovative drugs, already authorized in Europe, in a special band called the &#039;Cnn&#039; band, or &#039;C non-negotiated&#039; band. The drugs in this range are therefore available on the market and can be prescribed, but not paid for by the National Health Service. In the period in which the drugs remain in this range, the availability is more<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;Per gli esperti, in questo modo viene violato il diritto alla salute dei pazienti. Cos&igrave; in una lettera aperta indirizzata al ministro della Salute, Aiom e Cipomo denunciano la situazione minacciando un ricorso alla Consulta. &quot;I tempi previsti per rendere disponibili queste terapie non sono rispettati. Gravi le discriminazioni per i malati&rdquo;. 21 LUG&nbsp;&#8211; Gli &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18268"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18268\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}